TripleG 5 mg

Triple G 5 mg – an advanced research peptide with a tri-agonist receptor profile

TripleG 5 mg GLP-1, GIP, and the glucagon receptor are the three receptors that Triple G, an experimental peptide, interacts with. Compounds having this characteristic, referred to as “tri-agonists,” are examined in the scientific literature in terms of intricate receptor signaling and metabolic response processes in experimental models.

Triple G is a chemical of interest in the investigation of regulatory circuits associated with energy and metabolic homeostasis because of its unique “tri-agonist” receptor profile.

What sets Triple G apart in the context of the research?

• tri-agonist receptor profile (GLP-1 / GIP / glucagon)
• compound analyzed in the literature in the area of peptide receptor signaling
• focus of research interest in metabolic response and energy homeostasis
• advanced research peptide used in analyses of biological mechanisms

Scientific context (research focus)

Scientific papers cite GLP-1, GIP, and glucagon profile chemicals as research tools for studying regulatory systems related to hormonal signaling and metabolic response. The interpretation of the results, which is dependent on the study model, methodology, and approved endpoints, is not the basis for promises of impact in humans.

PRODUCT INTENDED FOR RESEARCH PURPOSES!

ADDITIONAL INFORMATION:

• The product (substance) is not a food or dietary supplement, not suitable for human consumption.
• Protect from children.
• Keep the container tightly closed.
• Store in a dry, cool, shaded place; protect from moisture.
• Store only in the original container.
• Avoid contact during pregnancy and breastfeeding.
• Consult a physician in case of ill health or adverse reactions related to contact. TripleG 5 mg